After 85 years, antibiotics are growing impotent. So what will medicine, agriculture and everyday life look like if we lose these drugs entirely? A few years ago, I started looking online to fill in chapters of my family history that no ...
Tags: imagining, post-antibiotics, future
Scientists from the medical sciences division at Penn State University have discovered that a compound in fish oil appears to target leukemia stem cells and could lead to a cure for the disease. The compound is a natural extract from EPA, ...
Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
Using plasmas, sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. Cell culture bags of this kind are an important aid for research and clinical purposes and may ...
Wyss Institute for Biologically Inspired Engineering of Harvard University has secured a $5.6m contract from the U.S. Food and Drug Administration for its organs-on-chips technology to assess medical countermeasures for treating acute ...
The European Commission has granted orphan drug designation to BrainStorm Cell Therapeutics’ stem cell therapy NurOwn to treat Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease. NurOwn consists of autologous ...
Tags: Orphan Drug, Medicine
Switzerland-based Celgene International Sárl has received approval from the European Commission (EC) to allow its Revlimid drug to treat patients with transfusion-dependent anaemia. While other remedial options could not yield ...
Biomaterials company Etex has announced the renewal and long-term extension of its supply agreement with Knee Creations. As per the agreement, Knee Creations will use Etex's patented nanocrystalline calcium phosphate technology in its ...
Tags: Etex, Knee Creations
French authorities have found 57 tons of banned mutton at the French company Spanghero, which was earlier implicated in the horsemeat scandal. Spanghero operates a factory in Castelnaudary, near Toulouse, in south-west France. The meat ...
The USFDA has granted orphan drug designation to Pluristem Therapeutics' PLacental eXpanded (PLX) cells to treat aplastic anemia. The failure of hematopoietic stem cells (HSCs) present in the bone marrow to produce red blood cells, white ...
Tags: orphan drug, aplastic anemia, drug
Sequenta has introduced a sequencing-based test for minimal residual disease (MRD) for leukemia and lymphoma. The ClonoSIGHT test utilizes the company's proprietary LymphoSIGHT technology, which works by sequencing DNA signatures that are ...
Tags: Sequenta, sequencing-based test, minimal residual disease
NanoSight, leading manufacturers of unique nanoparticle characterisation technology, reports on the breakthrough cancer metastasis research of Dr Hector Peinado Selgas and Dr David Lyden's research team from Weill Cornell Medical College. ...
Tags: NanoSight, cancer metastasis, characterisation technology
Fluorescence In Situ Hybridisation (FISH) is used in the leukemia diagnostics to determine the specific type of leukemia disease. Samples of blood or bone marrow are used in a short term cell culture to receive cells in the metaphase ...
Tags: FISH, leukemia disease, bone marrow
The FDA has approved Clinigen Healthcare's supplemental new drug application (sNDA) for Foscavir (foscarnet sodium), a treatment for HIV/AIDS-related cytomegalovirus (CMV) infections and herpes. Hospira will distribute Foscavir to US ...
One day, pharmaceutical companies might not have to test new drugs on animals or even humans. Instead, drugs could be tested with organ-on-a-chip technologies. These are not silicon chips that simulate organs or organisms, mind you; they ...
Tags: Organs, Chip, Harvard, Human Body, Silicon